Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| SU14813 | SU14813 is a multi-targeted receptor tyrosine kinases inhibitor with IC 50 s of 50, 2, 4, 15 nM for VEGFR2 , VEGFR1 , PDGFRβ and KIT. Uses: Scientific research. Group: Signaling pathways. CAS No. 627908-92-3. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-10501. |  |
| SU14813 | SU14813 is an oral, multitargeted tyrosine kinase inhibitor (TKI) targeting vascular endothelial growth factor receptors (VEGFR), platelet-derived growth factor receptors (PDGFR), KIT, and fms-like tyrosine kinase 3 (FLT-3) (1). SU14813 was developed as a next-generation TKI agent following sunitinib (SU11248) designed to demonstrate optimized pharmacokinetic (PK) and tolerability profiles. SU14813 demonstrated broad and potent antitumor activity equivalent to that of sunitinib, which resulted in tumor regression, growth arrest, growth delay, and prolonged survival in established xenograft cancer models in mice. Synonyms: SU 14813; SU-14813; SU014813; SU-014813; SU 014813. Grades: >98%. CAS No. 627908-92-3. Molecular formula: C23H27FN4O4. Mole weight: 442.491. |  |
| SU14813 maleate | SU14813 maleate is a multi-targeted receptor tyrosine kinases inhibitor with IC 50 s of 50, 2, 4, 15 nM for VEGFR2 , VEGFR1 , PDGFRβ and KIT. Uses: Scientific research. Group: Signaling pathways. CAS No. 849643-15-8. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg. Product ID: HY-10501A. | |
| SU14813 maleate | SU14813 maleate is an oral, multitargeted tyrosine kinase inhibitor (TKI) targeting vascular endothelial growth factor receptors (VEGFR), platelet-derived growth factor receptors (PDGFR), Kit, and fms-like tyrosine kinase 3 (FLT-3). It was developed as a next-generation TKI agent following sunitinib (SU11248) designed to demonstrate optimized pharmacokinetic (PK) and tolerability profiles. It demonstrated broad and potent antitumor activity equivalent to that of sunitinib, which resulted in tumor regression, growth arrest, growth delay, and prolonged survival in established xenograft cancer models in mice. Synonyms: SU14813 maleate; SU 14813 maleate; SU-14813 maleate. Grades: >98%. CAS No. 849643-15-8. Molecular formula: C27H31FN4O8. Mole weight: 558.56. | |
Our database is helping our users find suppliers everyday.
